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list control group with large effect sizes of Cohen’s d = 0.82 
(Y-BOCS SR) and d = 0.87 (OCI-R), using an intention-to-treat 
analysis. This effect remained stable at 6-month follow-up. 
Only 4 participants (12%) dropped out prematurely from the 
study. Of the 30 completers, 90% rated their condition as im-
proved and would recommend the program to their friends. 
 Conclusions: Internet-based writing therapy led to a signifi-
cant improvement of obsessive-compulsive symptoms. 
Even though replications with larger sample sizes are need-
ed, the results support the notion that Internet-based ap-
proaches have the potential for improving the treatment 
situation for patients with OCD.  © 2014 S. Karger AG, Basel 
 Obsessive-compulsive disorder (OCD) is a severe men-
tal disorder with an estimated lifetime prevalence of 2–3% 
 [1, 2] . OCD is characterized by intrusive thoughts, images 
or impulses (obsessions), usually followed by ritualized re-
petitive behavior (compulsions; e.g. hand-washing or 
checking) that aim at neutralizing the obsessive content. 
OCD causes significant functional impairment and dis-
tress and substantially affects the social and work situation 
 [3, 4] . If no adequate treatment is administered, OCD usu-
ally takes a relapsing course and becomes chronic  [5–7] .
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 Abstract 
 Background: Many patients with obsessive-compulsive dis-
order (OCD) do not receive first-line treatment according to 
the current guidelines (cognitive behavioral therapy with ex-
posure and response prevention, CBT with ERP) due to bar-
riers to treatment. Internet-based therapy is designed to 
overcome these barriers. The present study evaluates the ef-
ficacy of an Internet-based writing therapy with therapeutic 
interaction based on the concept of CBT with ERP for pa-
tients with OCD.  Methods: Thirty-four volunteers with OCD 
according to DSM-IV-criteria were included in the trial and 
randomized according to a waiting-list control design with 
follow-up measures at 8 weeks and 6 months. The interven-
tion consisted of 14 sessions, either starting directly after 
randomization or with an 8-week delay. Main outcome mea-
sure was the change in the severity of OCD symptoms (Yale-
Brown Obsessive Compulsive Scale Self-Rating, Y-BOCS SR, 
and Obsessive-Compulsive Inventory-Revised, OCI-R).  Re-
sults: Obsessive-compulsive symptoms were significantly 
improved in the treatment group compared to the waiting-
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 Cognitive-behavioral therapy (CBT) with stimulus ex-
posure and response prevention (ERP) is the first-line 
treatment for OCD according to standard guidelines  [8] . 
Response rates between 63 and 90% were reported  [9] . 
However, about 30% of patients drop out of the treatment 
prematurely  [10, 11] . Pre-post effect sizes, compared to a 
control group, range from d = 0.281 to d = 1.590 with a 
mean effect size of d = 0.998  [12] . A newer meta-analysis 
reported an even higher mean effect size of g = 1.39  [13] . 
Even though there is substantial evidence for its effective-
ness  [14, 15] , many patients do not receive this treatment 
 [16, 17] .
 Several barriers to treatment have been identified, in-
cluding logistic and financial barriers, as well as shame 
and the fear of stigmatization or discrimination  [18] . The 
resulting consequences reflect in the long delay from the 
onset of the disorder until the first treatment, on average 
11 years  [19] . Thus, there is a demand for new develop-
ments in the psychotherapeutic care of OCD. To bridge 
this gap, low-threshold options are needed that are time-
efficient and can be integrated into the daily routine of the 
therapist and patient.
 Telemental health (TMH) approaches have the poten-
tial to improve the insufficient treatment situation. Pre-
liminary evidence suggests that these approaches repre-
sent a low-threshold, efficacious, time-effective and eco-
nomic treatment for patients with OCD  [20] . The 
different TMH approaches for the treatment of OCD 
range from unguided self-help through online interven-
tions with minimal therapist involvement to video-based 
psychotherapy [for an overview see  20 ]. High dropout 
rates in studies on unguided self-help approaches [e.g.  21 ] 
suggest that the implementation of therapeutic interac-
tion seems advisable.
 Andersson et al.  [22] applied a partly tailored, but oth-
erwise standardized self-help manual in a pilot study and 
in a randomized controlled trial  [23] and included e-mail 
contact with a therapist. This method comes close to the 
therapist-supported writing therapy, an approach that has 
been used in the treatment of various other disorders with 
good results (including posttraumatic stress disorder  [24–
26] , complicated grief  [27, 28] , social phobia  [29–31] , pan-
ic disorder  [32, 33] , generalized anxiety disorder  [34, 35] , 
depression  [36, 37] and burnout  [38] ). However, thera-
pist-supported writing therapy goes beyond a self-help ap-
proach with therapist contact. As a half-standardized ap-
proach, it holds the possibility to individually adjust the 
tasks to the patient. Despite this promising prospect, In-
ternet-based writing therapy with therapeutic interaction 
has not yet been investigated as a treatment for OCD  [20] .
 The present study tested the hypotheses that (1) an In-
ternet-based, therapist-guided writing therapy (CBT with 
ERP) will be accepted by participants with OCD (treat-
ment satisfaction, rate of completers), (2) this treatment 
is efficient and leads to a significant reduction of OC 
symptoms in comparison to a waiting-list control group 
and (3) symptom reduction can be maintained for a pe-
riod of 6 months.
 Material and Method 
 Recruitment 
 The study was approved by the ethics committee in Freiburg 
and was registered in the German Clinical Trials Register (main 
ID: DRKS00004612). Written informed consent was obtained 
from all study participants. We recruited participants from May 
2011 until April 2012 through public media and websites for OCD 
as well as through outpatient psychiatrists who recommended the 
treatment to their patients.
 To be included in the study, participants had to undergo a four-
step assessment. Inclusion criteria were a diagnosis of OCD ac-
cording to DSM-IV criteria as their primary (most severe) disor-
der, fluency in written and spoken German, access to the Internet 
for the treatment period, age 18–65 years and an agreement by 
their outpatient psychiatrist for crisis intervention. We excluded 
participants who had another relevant current or past mental dis-
order, including a severe major depressive episode, an organic 
brain disorder, substance abuse or dependence, suicidal ideation, 
psychotic episode, psychotherapeutic treatment or an OCD-spe-
cific treatment with ERP in the last 5 years. Participants had to be 
free from or on a stable psychotropic medication for at least 
3 months. The inclusion and exclusion criteria were assessed in an 
extensive telephone interview by an experienced clinical master-
level psychologist according  to DSM-IV criteria. Further, the as-
sessment consisted of the completion of an online survey that in-
cluded the below-described measures and additional demograph-
ic questions, the consultation of an outpatient psychiatrist who 
confirmed the diagnosis and a second telephone interview to assess 
symptom severity and clarify any ambiguities from the previous 
steps ( fig. 1 ). In case participants did not meet the above criteria 
they received information about other treatment options. Consult-
ing the psychiatrist was of special importance, since this confirmed 
the diagnosis and guaranteed a fallback crisis intervention (al-
though it turned out not to be needed). Thereby, a high quality was 
ensured.
 Study Design 
 The study followed a randomized, controlled, waiting-list con-
trol group (WLCG) design. Participants were randomized to one 
of the two experimental conditions (immediate therapy start 
group, ISG, vs. WLCG) using a block randomization with ran-
domly permuted blocks. They received access to the secure web-
based communication system. The WLCG started the treatment 
with a delay of 8 weeks (duration of the treatment). The outcome 
measures were assessed at five time points. The baseline measure 
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sessment took place before the intervention (T 0 ), which was after 
the waiting period for those in the waiting-list condition. Both 
groups were assessed directly after the treatment (T 1 ), as well as 
8 weeks (T 2 ) and 6 months (T 3 ) after the end of the treatment.
 Outcome Measures 
 Yale-Brown Obsessive Compulsive Scale (Y-BOCS). The Y-
BOCS  [39] is a well-established semistructured interview that 
measures the severity of intrusive thoughts and compulsive behav-
ior. It was used a single time in the screening process to assess the 
severity and also to verify the data of the self-report version of the 
Y-BOCS.
 The self-report version of the Y-BOCS (Y-BOCS SR)  [40] was 
used as the primary outcome criterion. The questionnaire consists 
of 10 questions. Each question is rated on a 5-point Likert scale, 
scoring between 0 (no symptoms) and 4 (severe symptoms), there-
by allowing for a total score between 0 and 40. Subscores for obses-
sions (0–20) and for compulsions (0–20) can be calculated. The 
Y-BOCS has good psychometric characteristics  [39] . The self-re-
port version correlates highly with the original scale  [41, 42] , thus 
allowing a good assessment of the severity of OCD symptoms via 
the Internet.
 Obsessive-Compulsive Inventory-Revised (OCI-R). The OCI-R 
 [43] is a self-report measure for assessing symptoms of OCD. It 
Enrollment Excluded (n = 31)
Current psychotherapy with ERP, or within last
5 years: n = 17
No (or sublinical) OCD: n = 11
Major depressive disonder: n = 2
Decision for in-patient treatment: n = 1
Applied for the study,
telephone assessment for eligibility
(n = 77)
Excluded (n = 2)
Severity of OCD below cutoff: n = 1
Technical difficulties with internet usage: n = 1








Excluded (n = 7)
Change in medication: n = 2
Major depressive disorder: n = 1
Did not get a psychiatrist৕s appointment: n =1
Beginning of a face-to-face treatment: n = 1
Did not respond to contact: n = 2
Excluded (n = 3)
OCD not primary disorder: n = 1
Beginning of or decision for a face-to-face
treatment: n = 2
Completed 8-week-FU: n = 16
Completed 6-month-FU: n = 16
Completed 8-week-FU: n = 13
Completed 6-month-FU: n = 12
Analyzed: n = 18
Allocated to ISG (n = 16)
Completed treatment: n = 16
Allocated to WLCG (n = 18)
Completed waiting period: n = 16




Analyzed: n = 16



















   
   
   
   
   
   
   
   
   

























contains 18 items and 6 subscales and has good psychometric 
properties  [43–45] . These also apply to the German version  [46] . 
The following instruments were used to measure the general psy-
chopathology. The Beck Depression Inventory-II (BDI-II)  [47] as-
sesses the severity of depression while the Brief Symptom Inven-
tory (BSI)  [48] , as a short form of the Symptom Checklist 90-Re-
vised (SCL-90R)  [49] , measures the subjectively perceived 
impairment of a person caused by physical and psychological 
symptoms over a period of 7 days.
 Patient Global Impression of Improvement Scale (PGI-I). The 
PGI-I is a one-item scale for assessing the global improvement 
compared to the start of treatment. The 7-point item ranges from 
‘very much better’ (+3) to ‘no change’ (0) to ‘very much worse’ 
(–3).
 Internet-Specific Questions. In addition to the symptomatic in-
struments, self-constructed questions concerning participants’ 
satisfaction with the Internet-based contact were asked (e.g. How 
did you experience being treated via the Internet instead of face-
to-face?). They were constructed as multiple-choice questions al-
lowing for additional open answers.
 Internet-Based Therapy 
 The 8-week treatment was implemented as a half-standard-
ized, Internet-based writing therapy with therapeutic interac-
tion. All communication between the participant and therapist 
took place exclusively via the Internet. The treatment consisted 
of 14 sessions (twice a week with the exception of the first and 
the last week), which were based on established and evidence-
based cognitive-behavioral manuals and methods  [50] . The 
treatment was conducted by 3 experienced cognitive behavioral 
therapists, each with at least 4 years of therapeutic expertise. Ev-
ery participant was assigned to one individual therapist for the 
treatment period. Therapists received supervision every fourth 
session. Treatment adherence was controlled by a licensed cog-
nitive behavioral therapist specialized in the treatment of OCD. 
Participants received instructions or exercises for the respective 
sessions from their study therapists via a secure web-based com-
munication system. After completing these tasks, they replied in 
written form and shared their experience with the therapist. The 
therapist then provided individual feedback and requests for the 
previous task, as well as the largely standardized instructions for 
the next task. The study protocol guaranteed the participants a 
reply of their therapist within one business day. To ensure this, 
the participants were asked to set themselves two deadlines a 
week for their work on the tasks and to communicate their dead-
lines to their therapist.
 The overall emphasis was placed on the realization of ERP as 
recommended in guidelines as the treatment of first choice for 
OCD  [51] . The content of the treatment was divided into three 
phases. The first phase served to identify relevant problem areas, 
to provide psychoeducation about OCD and to prepare for ERP. 
In the second phase, participants exposed themselves to the rel-
evant stimuli, starting with an imaginary confrontation (expo-
sure in sensu). This served to identify and anticipate potential 
difficulties. Afterwards, participants carried out three exposure 
sessions in vivo with each session increasing in difficulty. Par-
ticipants were encouraged to generalize the newly acquired skills 
to different OCD-associated situations. The final phase centered 
on the identification and modification of precipitating and 
maintaining factors of the obsessive behavior, the development 
of strategies for relapse prevention as well as a review of the 
treatment. During the entire treatment phase, participants com-
pleted weekly adverse event questions as a safety measure. In 
case of a significant worsening, a telephone appointment was 
established.
 Strategy of Data Analysis/Statistical Procedures (Analysis) 
 Data were analyzed using IBM SPSS Statistics for Windows 
(IBM Corp., Armonk, N.Y., USA). Participants who did not com-
plete the intervention (treatment period for the ISG, waiting and 
treatment period for the WLCG) as well as the posttreatment mea-
sures were considered as dropouts. An intention-to-treat analysis 
was employed. Considering the rather stable nature of OCD, miss-
ing data were imputed by the Last-Observation-Carried-Forward 
method.
 The equivalence of the randomized groups at baseline was eval-
uated by calculating independent sample t tests for continuous 
variables and Pearson’s χ 2 for categorical variables. Following rec-
ommendations  [52,  53] , the inferential confidence interval meth-
od was used as a second test for equivalence.
 To evaluate the efficacy of the intervention, data collected be-
fore and after the treatment (ISG) were compared to the data be-
fore and after the waiting period (WLCG) computing a two-way 
analysis of variance (ANOVA) with the repeated measures factor 
Time and the between-subject factor Group (ISG, WLCG).
 In order to allow for statements on the stability of the thera-
peutic effect, the two groups were combined and pre-post inter-
vention data were analyzed (within-subject measures without 
group comparison). Specifically, the data collected at T 0 (prior to 
the intervention phase in both groups), T 1 , T 2 and T 3 were ana-
lyzed (i.e. the assessment T –1 prior to the waiting time of the 
WLCG was not included). A one-way ANOVA with the repeated 
measures factor Time and contrasts relative to the pre-measure 
(T 0 ) was calculated.
 Clinical significance of change was defined according to the 
criteria by Jacobson and Truax  [54] . Their method includes the 
calculation of (a) an index for a reliable symptom improvement 
(reliable change index, RCI) and (b) a cutoff for the symptom se-
verity after the treatment. To apply these criteria to the Y-BOCS, 
the procedure of Fisher and Wells  [55] with a cutoff of 14 points 
on the Y-BOCS SR was used. Finally, means and standard devia-
tions were calculated for the global ratings of life and treatment 
satisfaction (PGI-I) as well as for the Internet-specific questions.
 Due to the number of tests, the level of significance was set to 
p  ≤ 0.01 in order to counteract a potential α-error inflation. For a 
classification of the therapeutic success, effect sizes were derived 
by calculating Cohen’s d based on the pooled standard deviation. 
To indicate the average time therapists spent for a treatment ses-
sion means were calculated.
 Results 
 Demographic Characteristics 
 Seventy-seven potential participants responded to the 
public notice of the study. A majority of 43 were exclud-
ed in the screening process due to various reasons (see 
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exclusion criterion of a previous OCD-specific treatment 
in the last 5 years. Thirty-four participants met the inclu-
sion criteria and entered the study. Following the 
 CONSORT recommendations  [56] , the flow of partici-
pants through the trial is shown in  figure 1 . The mean age 
of the sample was 35.56 years (SD = 9.38, range = 19–59), 
22 of the participants were female (65%), 12 were male 
(35%). Overall, 24 participants (71%) had a history of 
psychotherapeutic treatment with an average of 1.79 
treatments (SD = 1.32). Only 3 of them reported to have 
experience with ERP. Most participants (n  = 25) were 
free from psychotropic medication, only a minority of 9 
participants were on a stable medication, mostly with se-
lective serotonin reuptake inhibitors. The mean Y-BOCS 
SR total score was 20.12 (SD = 9.38), with 9.15 (SD = 3.70) 
for the obsessions and 10.97 (SD = 3.82) for the compul-
sions subscale. The clinician-administered version of the 
Y-BOCS showed a high correlation of 0.81 (p < 0.001) 
with the self-rating version, thereby indicating that the 
self-rating assessment is a valid measure of symptom se-
verity.  Table 1 provides an overview of the characteristics 
of both groups at baseline.
Table 1.  Demographic description of the participants
Characteristic ISG (n = 16) WLCG (n = 18)  Statistics p
Gender
Women/men 11/5 11/7 χ2(1) = 0.21 0.642
Mean age ± SD, years 38.19±8.80 33.22±9.50 t(32) = 1.574 0.125
Min–max 28–59 19–55
OCD duration
Mean length ± SD, years 15.00±8.57 13.11±11.10 t(31) = 0.538 0.594
Mean age at onset ± SD, years 23.73±9.70 20.17±6.72
Mean baseline scores ± SD
Y-BOCS SR 20.25±6.71 20.00±5.40 t(32) = 0.120 0.905
OCI-R 26.00±10.03 25.89±10.00 t(32) = 0.032 0.974
BDI-II 13.75±9.11 13.22±8.36 t(32) = 0.176 0.861
Education
Mean duration ± SD, years 15.56±3.69 17.72±5.99 t(32) = 1.247 0.222
Secondary education
No educational qualifications – (0) – (0)
Lower secondary education (‘Hauptschule’) – (0) – (0)
High school diploma (‘Realschule’) 3 (19) 2 (11)
International baccalaureate (‘Abitur’) 12 (75) 14 (78)
Other 1 (6) 2 (11)
Distribution of the qualifications above Fisher-Yates 0.858
Employment
Working full time 7 (44) 9 (50)
Working part-time 4 (25) 4 (22)
Not working 4 (25) 3 (17)
Unemployed 1 (6) 2 (11)
Distribution of the employments above Fisher-Yates 0.957
Living situation
Living with partner 12 (75) 11 (61)
Living alone 1 (6) 3 (17)
Other 3 (19) 4 (22)
Distribution of the living situations above Fisher-Yates 0.762
Family status
Single 7 (44) 13 (72)
Married 9 (56) 5 (28)
Divorced – (0) – (0)
Widowed – (0) – (0)
Distribution of the family status above Fisher-Yates 0.163
 SD = Standard deviation. Figures in parentheses are percentages. In the statistics column, figures in paren-



















   
   
   
   
   
   
   
   
   


























 Out of the 34 participants who started the treat-
ment phase, 30 completed the protocol and the post-
treatment survey. Only 4 participants (12%) dropped 
out prematurely and all of them had been allocated to 
the WLCG. Two left the study during the waiting 
 period (1 found another treatment, another one’s 
OCD symptoms subsided), the other 2 left in the treat-
ment phase, immediately before the start of the ERP 
sessions. Twenty-nine participants completed the first 
follow-up assessment, 28 the final assessment after 
6 months.
 Treatment Efficacy 
 As a prerequisite for calculating group comparisons, 
the equivalence at baseline was tested. Both groups 
showed no significant differences regarding age, gender, 
education and symptom severity at baseline at a level of 
significance of 0.10, which should allow for a sensitive 
detection of differences (see  table 1 for details). Even if the 
inferential confidence interval method was applied, no 
group differences emerged.
 The comparison of the ISG with the WLCG revealed 
significant Group × Time interactions for the OCD symp-
toms both on the Y-BOCS SR [F(1, 32) = 9.150, p = 0.005] 
and on the OCI-R [F(1, 32) = 18.803, p < 0.001] as well as 
for the depressive symptoms on the BDI-II [F(1, 32) = 
14.710, p = 0.001]. The main effect for both groups over 
time (pre-post) showed significant improvements for all 
three measures – Y-BOCS SR [F(1, 32)  = 14.506, p  = 
0.001], OCI-R [F(1, 32) = 37.413, p < 0.001], and BDI-II 
[F(1, 32) = 24.514, p < 0.001]. In terms of the magnitude, 
the results showed only minimal mean improvements for 
the WLCG (Y-BOCS SR: 0.67, OCI-R: 1.78, BDI-II: 0.78) 
contrasting considerable improvements for the ISG (Y-
BOCS SR: 5.81, OCI-R: 10.44, BDI-II: 6.13). The im-
provements on the OCD-related measures compared to 
the WLCG both yielded large effect sizes of d = 0.82 (Y-
BOCS SR) and d = 0.87 (OCI-R). Those on the BDI-II 
reached a medium effect size with d = 0.56. Results also 
revealed larger improvements on the Y-BOCS compul-
sions subscale [F(1, 32) = 19.689, p < 0.001] than on the 
Y-BOCS obsessions subscale [F(1, 32) = 5.516, p = 0.025]. 


























WLCG (n = 18)
ISG (n = 16)
 Fig. 2. Scores of the main outcome mea-
sures, contrasting the pre-post compari-
sons for both study conditions (i.e. Internet 
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 Stability of the Treatment Effects 
 The analysis of all participants confirmed the highly 
significant symptom reduction on the Y-BOCS SR [F(1, 
33) = 16.626, p < 0.001], on the OCI-R [F(1, 33) = 22.471, 
p < 0.001] and on the BDI-II [F(1, 33) = 15.172, p < 0.001]. 
The evaluation of the contrasts (T 1 vs. T 0 , T 2 vs. T 0 , T 3 vs. 
T 0 ) showed that all these scores differed significantly 
from the pretreatment score. The corresponding effect 
sizes even revealed a slight improvement at the 8-week 
and the 6-month follow-up with numbers up to d = 0.97 
( table 2 ). This result indicates a stability of the achieved 
symptom reductions over 6 months after treatment 
( fig. 3 ). It bears mentioning that by analyzing the larger 
sample, both the Y-BOCS obsessions subscale [F(1, 33) = 
5.544, p = 0.007] and the compulsions subscale [F(1, 33) = 
24.088, p < 0.001] showed a highly significant reduction, 
which remains stable over time.
 Clinical Significance 
 The comparison of the 16 participants of the ISG after 
the treatment with the 16 completers of the WLCG after 
the waiting period showed that in both groups partici-
pants scored equal or below a cutoff of 14 points on the 
Y-BOCS SR (ISG: 7, 44%; WLCG: 3, 19%), thereby fulfill-
ing the cutoff criterion. However, the mean improvement 
these responders had on the Y-BOCS differed widely (ISG: 
8.00 points, WLCG: 1.67 points). Four (25%) participants 
in the ISG had a symptom improvement of 10 or more 
Table 2.  Main outcome measures for both study conditions before and after treatment/waiting period, as well as 
for all participants before and after treatment
Measure  Treatment effectiveness Treatment stability
ISG (n = 16) WLCG (n = 18) ES all participants
after treatment
(n = 34)  
ES
Y-BOCS SR score
Before treatment/waiting period 20.25±6.71 20.00±5.40
After treatment/waiting period 14.44±5.90 19.33±6.46 0.82
Y-BOCS SR obsessions score
Before treatment/waiting period 9.19±4.26 9.11±3.25
After treatment/waiting period 7.25±2.95 8.50±3.91 0.34
Y-BOCS SR compulsions score
Before treatment/waiting period 11.06±4.30 10.89±3.46
After treatment/waiting period 7.19±3.65 10.83±3.73 0.95
Y-BOCS SR score
Before treatment 19.76±6.49
Immediately after treatment 15.15±6.93 0.83
8 weeks after treatment 14.56±7.70 0.93
6 months after treatment 14.79±7.09 0.89
OCI-R score
Before treatment/waiting period 26.00±10.03 25.89±9.99
After treatment/waiting period 15.56±8.93 24.11±10.84 0.87
Before treatment 25.00±10.35
Immediately after treatment 17.76±10.62 0.83
8 weeks after treatment 16.41±11.01 0.97
6 months after treatment 17.44±10.54 0.86
BDI-II score
Before treatment/waiting period 13.75±9.11 13.22±8.36
After treatment/waiting period 7.62±7.54 12.44±8.61 0.56
Before treatment 13.06±8.74
Immediately after treatment 8.29±7.02 0.60
8 weeks after treatment 8.26±7.20 0.61
6 months after treatment 7.41±7.04 0.71



















   
   
   
   
   
   
   
   
   

























points (i.e. fulfilled the RCI criterion), whereas no partici-
pant in the WLCG fulfilled this criterion. When consider-
ing all participants, 16 (53%) of the 30 completers scored 
equal or below the cutoff after the treatment, 5 (17%) ful-
filled the RCI criterion. These scores slightly improved at 
the follow-up measures. After 8  weeks 17 of 29 (59%) 
scored below the cutoff and 7 of 29 (21%) fulfilled the RCI. 
After 6 months 16 of 28 (57%) scored below the cutoff and 
6 of 28 (21%) fulfilled the RCI. The percentage of partici-
pants meeting the corresponding criteria of a  ≥ 30% Y-
BOCS reduction rose from 40% (12 of 30) after the treat-
ment to 45% (13 of 29) after 8 weeks and cumulated in 54% 
(15 of 28) 6 months after the treatment.
 Perceived Improvement 
 After the treatment, 90% (n = 27) of the 30 completers 
rated their condition on the PGI-I as improved, 14 (47%) 
of them as much improved and 2 (7%) as very much im-
proved. Two (7%) reported no change, only 1 (3%) a 
worsening of symptoms.
 Treatment Satisfaction and Adverse Events 
 Concerning the Internet-specific questions, 29 of the 
30 completers (97%) described the contact with their 
therapist as personal. Only 17% missed face-to-face con-
tact with a therapist. Eighty percent of the completers had 
a positive attitude towards a treatment via the Internet 
instead of face-to-face contact. As a rather indirect mea-
sure of treatment satisfaction, 90% would recommend the 
program to other persons with OCD.
 No adverse events were reported during the treatment 
and in the ensuing 6 months.
 Therapist Time 
 Looking at all treatment completers, therapists spent 
an average of 33 min (SD = 9.03) per treatment session. 
A separate analysis of both halves of the treatment showed 
that the mean therapist time per session dropped from 
37 min (SD = 10.39) for the first half of the patients down 
to 29 min (SD = 5.07) for the second half.
 Discussion and Conclusion 
 This study provides evidence for the feasibility and ef-
ficacy of an Internet-based, therapist-guided CBT with 
ERP for treating patients with OCD.
 Consistent with our hypotheses, the approach proved 
to be effective for individuals suffering from OCD with 
significantly higher symptomatic improvements in the 
treatment group (ISG) compared to the WLCG. The 
treatment led to significant reductions of the main 
symptoms of OCD on both self-reported symptom 
scales, the Y-BOCS SR and OCI-R, and of depressive 
symptoms (BDI-II). The effect sizes of the treatment on 
the primary outcome measures were large and remained 
stable within the 6-month follow-up period after treat-
ment. The d values of 0.82 and 0.87 after the treatment 
fell within the range reported by Rosa-Alcázar et al.  [12] 
and Olatunji et al.  [13] in their meta-analyses about 
studies on Cognitive Therapy with ERP, and paralleled 
those that Cuijpers et al.  [57] described for TMH ap-
proaches for anxiety disorders. We cannot exclude the 
use of other therapies as an influencing factor for the 
maintenance of the successes in the follow-up period, 
but in the light of the results of other TMH approaches 
for OCD  [20] the interpretation seems valid that the suc-
cess is due to the present intervention. One important 
factor which probably contributed to the efficacy of the 
intervention is that ERP was implemented, since this 
seems to be of particular importance for TMH ap-
proaches for OCD [compare  20 ]. To put the effect sizes 
into perspective in the overall context, the low intensity 
of the treatment (i.e. 14 sessions, 8 weeks) has to be con-
sidered. Looking at research on the dose-effect in psy-
chotherapy  [8, 58, 59] , it can be assumed that a prolon-
gation of the treatment may lead to even better results 
with higher effect sizes.
 Regarding the effects on obsessions and compul-
sions, closer examination revealed a greater improve-
ment in compulsions than obsessions. This corresponds 
with the findings of other authors  [60, 61] . A self-help 
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 Fig. 3. Scores of the main outcome measures for all participants 
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ducing the obsessive thoughts and yielded good results. 
Therefore, for a subsequent research project, it is impor-
tant to select single components of such a program in 
order to achieve a stronger improvement of obsessive 
thoughts.
 While unguided self-help often struggles with extreme 
dropout rates (e.g. 74% of the participants in BT-Steps 
 [21,  63] ), TMH approaches with therapeutic interaction 
have higher acceptance rates  [20, 64] . The present study 
confirms this result. The low dropout rate of 12% (all of 
them in the WLCG) demonstrates the high acceptance of 
the program. The dropout rate is comparable or even 
lower than those of traditional face-to-face treatments 
 [10, 11] . Besides the intense therapeutic interaction, the 
specific selection criteria might provide an explanation 
not only for the surprisingly low number of participants 
fulfilling inclusion criteria and finally entering the study, 
but also for the low dropout rate. Likewise, the reported 
improvement rate of 90% among completers, as well as 
the equally high percentage of participants willing to rec-
ommend the program to others pointed to the high ac-
ceptance of the program. Together, we clearly corrobo-
rated our hypothesis concerning compliance and accep-
tance.
 With regard to clinical significance, more than half 
of the completers had a Y-BOCS SR score equal or be-
low 14 points on the Y-BOCS SR after the treatment. 
Yet, only 5 participants had a 10-point improvement. 
Together with the highly significant symptom improve-
ment, the large effect sizes and the fact that 90% of the 
completers subjectively experienced an improvement, 
the results suggest the efficacy of the treatment. How-
ever, modification is required to obtain an even better 
response. In the present study, a Y-BOCS score of 8 
points or less constituted an exclusion criterion. The 
overall Y-BOCS SR score of 20.12 was lower than in 
other studies  [65–68] . Therefore, participants with a 
low level of suffering were included, which did not leave 
much room for improvement. As mentioned above, a 
prolongation of the treatment program would be a use-
ful step. Some participants explicitly inquired at the end 
of treatment whether an extension was possible, since 
they wanted to build onto their successes.
 Compared to a typical 50-min face-to-face therapy 
session, in the present study the mean therapists time was 
reduced by 17 min per session. Moreover, the data indi-
cated a training effect over time. In the second half of the 
treatment, therapists needed only 29 min, that is 8 min 
less than in the first half. Overall, this leaves the therapist 
with more time for other patients.
 The present study has several limitations. Most im-
portantly, it did not include an active control group. 
Due to this lack, the findings must be considered pre-
liminary and require replication with an active control 
group in a larger sample. To allow for a better grading 
of the effect sizes, it would be useful to compare the 
Internet-based treatment with a traditional face-to-face 
CBT. Likewise, the comparison with an unguided self-
help approach with identical content would be needed 
to gauge the impact of the therapeutic contact on the 
therapy outcome. Furthermore, the fact that partici-
pants were recruited through public media, websites 
and outpatient psychiatrists, may have led to a wide het-
erogeneity of the sample. This could hamper the inter-
pretability of the results. In order to make statements 
about the differential efficacy it would be desirable to 
calculate analyses regarding subgroups (e.g. self-select-
ed participants vs. participants referred by the psychia-
trist, participants with washing, checking or hoarding 
behavior). Due to the limited sample size no such anal-
yses were possible.
 Regarding clinical implications, the present study sug-
gests a similar efficacy of an Internet-based treatment for 
OCD as with traditional face-to-face CBT. Even though 
the findings are of a preliminary nature, evidence sug-
gests that Internet-based writing therapy is a treatment 
option for OCD. This offers the opportunity to overcome 
a number of treatment barriers, such as a poor infrastruc-
ture for psychotherapy in many areas of the world and 
limitations related to business hours. Since no direct ther-
apist contact occurs, the approach opens a virtual space 
that might help overcome shame and the fear of stigma-
tization. All in all, Internet-based writing therapy offers a 
valuable addition to existing treatment options. It could 
be used in the context of a stepped care approach with a 
further need of identifying the best treatment allocation 
for patients with OCD.
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